Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2015

Open Access 01-12-2015 | Research

Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data

Authors: Aram S Modrek, Howard C Hsu, Cynthia G Leichman, Kevin L Du

Published in: Radiation Oncology | Issue 1/2015

Login to get access

Abstract

Background

Small cell carcinoma of the rectum is a rare neoplasm with scant literature to guide treatment. We used the Surveillance Epidemiology and End Results (SEER) database to investigate the role of radiation therapy in the treatment of this cancer.

Methods

The SEER database (National Cancer Institute) was queried for locoregional cases of small cell rectal cancer. Years of diagnosis were limited to 1988–2010 (most recent available) to reduce variability in staging criteria or longitudinal changes in surgery and radiation techniques. Two month conditional survival was applied to minimize bias by excluding patients who did not survive long enough to receive cancer-directed therapy. Patient demographics between the RT and No_RT groups were compared using Pearson Chi-Square tests. Overall survival was compared between patients who received radiotherapy (RT, n = 43) and those who did not (No_RT, n = 28) using the Kaplan-Meier method. Multivariate Cox proportional hazards model was used to evaluate important covariates.

Results

Median survival was significantly longer for patients who received radiation compared to those who were not treated with radiation; 26 mo vs. 8 mo, respectively (log-rank P = 0.009). We also noted a higher 1-year overall survival rate for those who received radiation (71.1% vs. 37.8%). Unadjusted hazard ratio for death (HR) was 0.495 with the use of radiation (95% CI 0.286-0.858). Among surgery, radiotherapy, sex and age at diagnosis, radiation therapy was the only significant factor for overall survival with a multivariate HR for death of 0.393 (95% CI 0.206-0.750, P = 0.005).

Conclusions

Using SEER data, we have identified a significant survival advantage with the use of radiation therapy in the setting of rectal small cell carcinoma. Limitations of the SEER data apply to this study, particularly the lack of information on chemotherapy usage. Our findings strongly support the use of radiation therapy for patients with locoregional small cell rectal cancer.
Literature
1.
Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39(6):707–12. doi:10.1097/MPA.0b013e3181ec124e. PubMed.PubMedCrossRef
2.
Smith J, Reidy-Lagunes D. The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas. Semin Oncol. 2013;40(1):100–8. doi: 10.1053/j.seminoncol.2012.11.011. PubMed.PubMedCrossRef
3.
Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61–72. doi:10.1016/S1470-2045(07)70410-2. PubMed.PubMedCrossRef
4.
Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40(1):1–18. doi:10.1016/j.ecl.2010.12.005. PubMed.PubMedCrossRef
5.
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72. doi: 10.1200/JCO.2007.15.4377. PubMed.PubMedCrossRef
6.
Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22(13):2730–9. doi:10.1200/JCO.2004.09.075. PubMed.PubMedCrossRef
7.
Robidoux A, Monte M, Heppell J, Schurch W. Small-cell carcinoma of the rectum. Dis Colon Rectum. 1985;28(8):594–6. PubMed.PubMedCrossRef
8.
Clery AP, Dockerty MB, Waugh JM. Small-cell carcinoma of the colon and rectum. A clinicopathologic study. Arch Surg. 1961;83:164–72. PubMed.PubMedCrossRef
9.
Brenner B, Shah MA, Gonen M, Klimstra DS, Shia J, Kelsen DP. Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer. 2004;90(9):1720–6. doi:10.1038/sj.bjc.6601758. PubMed PMID: 15150595; PubMed Central PMCID: PMC2409752.PubMedCentralPubMed
10.
Bernick PE, Klimstra DS, Shia J, Minsky B, Saltz L, Shi W, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum. 2004;47(2):163–9. PubMed.PubMedCrossRef
11.
Strosberg J, Nasir A, Coppola D, Wick M, Kvols L. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors. Hum Pathol. 2009;40(9):1262–8. doi: 10.1016/j.humpath.2009.01.010. PubMed.PubMedCrossRef
12.
Staren ED, Gould VE, Warren WH, Wool NL, Bines S, Baker J, et al. Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation. Surgery. 1988;104(6):1080–9. PubMed.PubMed
13.
Walenkamp AM, Sonke GS, Sleijfer DT. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma. Cancer Treat Rev. 2009;35(3):228–36. doi: 10.1016/j.ctrv.2008.10.007. PubMed.PubMedCrossRef
14.
Califano R, Abidin AZ, Peck R, Faivre-Finn C, Lorigan P. Management of small cell lung cancer: recent developments for optimal care. Drugs. 2012;72(4):471–90. doi:10.2165/11597640-000000000-00000. PubMed.PubMedCrossRef
15.
Kallianos A, Rapti A, Zarogoulidis P, Tsakiridis K, Mpakas A, Katsikogiannis N, et al. Therapeutic procedure in small cell lung cancer. J Thorac Dis. 2013;5 Suppl 4:S420–4. doi: 10.3978/j.issn.2072-1439.2013.09.16. PubMed PMID: 24102016; PubMed Central PMCID: PMC3791494.PubMedCentralPubMed
16.
Turrisi 3rd AT, Kim K, Blum R, Sause WT, Livingston RB, Komaki R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340(4):265–71. doi:10.1056/NEJM199901283400403. PubMed.PubMedCrossRef
17.
Spiliopoulou P, Panwar U, Davidson N. Rectal small cell carcinoma: a case report and review of the literature. Case Rep Oncol. 2011;4(3):475–80. doi:10.1159/000332760. PubMed PMID: 22114573; PubMed Central PMCID: PMC3220900.PubMedCentralPubMedCrossRef
18.
Okuyama T, Korenaga D, Tamura S, Yao T, Maekawa S, Watanabe A, et al. The effectiveness of chemotherapy with cisplatin and 5-fluorouracil for recurrent small cell neuroendocrine carcinoma of the rectum: report of a case. Surg Today. 1999;29(2):165–9. PubMed.PubMedCrossRef
19.
Joshua AM, Adams D, McKenzie P, Solomon M, Clarke SJ. Small blue cell tumors of the rectum. Case 2. Small-cell carcinoma of the rectum. J Clin Oncol. 2005;23(4):912–3. doi:10.1200/JCO.2005.03.094. PubMed.PubMedCrossRef
20.
21.
Cebrian J, Larach SW, Ferrara A, Williamson PR, Trevisani MF, Lujan HJ, et al. Small-cell carcinoma of the rectum: report of two cases. Dis Colon Rectum. 1999;42(2):274–7. PubMed.PubMedCrossRef
22.
Gupta S, Engstrom PF, Cohen SJ. Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors. Clin Colorectal Cancer. 2011;10(4):298–309. doi:10.1016/j.clcc.2011.06.006. PubMed.PubMedCrossRef
23.
Sarsfield P, Anthony PP. Small cell undifferentiated (‘neuroendocrine’) carcinoma of the colon. Histopathology. 1990;16(4):357–63. PubMed.PubMedCrossRef
24.
Brenner B, Tang LH, Shia J, Klimstra DS, Kelsen DP. Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Semin Oncol. 2007;34(1):43–50. doi:10.1053/j.seminoncol.2006.10.022. PubMed.PubMedCrossRef
25.
Medgyesy CD, Wolff RA, Putnam Jr JB, Ajani JA. Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review. Cancer. 2000;88(2):262–7. PubMed.PubMedCrossRef
26.
Meng MB, Zaorsky NG, Jiang C, Tian LJ, Wang HH, Liu CL, et al. Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma. Radiother Oncol. 2013;106(3):317–22. doi:10.1016/j.radonc.2013.01.008. PubMed.PubMedCrossRef
27.
Huncharek M, Muscat J. Small cell carcinoma of the esophagus. The Massachusetts General Hospital experience, 1978 to 1993. Chest. 1995;107(1):179–81. PubMed.PubMedCrossRef
28.
Matsui K, Kitagawa M, Miwa A, Kuroda Y, Tsuji M. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol. 1991;86(9):1167–75. PubMed.PubMed
29.
Sato Y, Fujisawa J, Saji Y, Misawa K, Yabuki H, Kotani H, et al. [A case of small cell undifferentiated carcinoma (SCUC) of the rectum treated with etoposide, cis-platinum and radiotherapy]. Gan To Kagaku Ryoho. 1992;19(13):2245–9. PubMed.PubMed
30.
Kosmidis C, Efthimiadis C, Anthimidis G, Vasiliadou K, Tzeveleki I, Fotiadis P, et al. Small cell carcinoma in ulcerative colitis–new treatment option: a case report. World J Surg Oncol. 2010;8:100. doi:10.1186/1477-7819-8-100. PubMed PMID: 21087512; PubMed Central PMCID: PMC2999595.PubMedCentralPubMedCrossRef
31.
Vergeli-Rojas JA, Santiago-Caraballo DL, Caceres-Perkins W, Magno-Pagatzartundua P, Toro DH, et al. Small cell neuroendocrine carcinoma of rectum with associated paraneoplastic syndrome: a case report. P R Health Sci J. 2013;32(1):51–3. PubMed.PubMed
32.
Khansur TK, Routh A, Mihas TA, Underwood JA, Smith GF, Mihas AA, et al. Syndrome of inappropriate ADH secretion and diplopia: oat cell (small cell) rectal carcinoma metastatic to the central nervous system. Am J Gastroenterol. 1995;90(7):1173–4. PubMed.PubMed
33.
Ree AH. A complex case of rectal neuroendocrine carcinoma with terminal delirium. Nat Clin Pract Gastroenterol Hepatol. 2006;3(7):408–13. doi:10.1038/ncpgasthep0525. PubMed. quiz 14.PubMedCrossRef
34.
Yaziji H, Broghamer Jr WL. Primary small cell undifferentiated carcinoma of the rectum associated with ulcerative colitis. South Med J. 1996;89(9):921–4. PubMed.PubMedCrossRef
35.
Gaffey MJ, Mills SE, Lack EE. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases. Am J Surg Pathol. 1990;14((11):1010–23. PubMed.CrossRef
36.
Sakamoto Y, Kitajima Y, Ogawa A, Hidaka K, Miyazaki K. [Successful combination chemotherapy for a case of small cell carcinoma of the rectum with multiple liver metastasis]. Gan To Kagaku Ryoho. 1999;26(4):543–7. PubMed.PubMed
37.
Hayashi H, Miyagi Y, Sekiyama A, Yoshida S, Nakao S, Okamoto N, et al. Colorectal small cell carcinoma in ulcerative colitis with identical rare p53 gene mutation to associated adenocarcinoma and dysplasia. J Crohns Colitis. 2012;6(1):112–5. doi: 10.1016/j.crohns.2011.08.009. PubMed.PubMedCrossRef
38.
Al-Jiffry BO, Al-Malki O. Neuroendocrine small cell rectal cancer metastasizing to the liver: a unique treatment strategy, case report, and review of the literature. World J Surg Oncol. 2013;11:153. doi:10.1186/1477-7819-11-153. PubMed PMID: 23844568; PubMed Central PMCID: PMC3717129.PubMedCentralPubMedCrossRef
39.
Kuratate S, Inoue S, Chikakiyo M, Kaneda Y, Harino Y, Hirose T, et al. Coexistent poorly-differentiated neuroendocrine cell carcinoma and non-invasive well-differentiated adenocarcinoma in tubulovillous adenoma of the rectum: report of a case. J Med Invest. 2010;57(3–4):338–44. PubMed.PubMedCrossRef
40.
Wu Y, Wang Q, Wang L, He X. Extrapulmonary Small Cell Carcinoma of the Rectum. Journal of gastrointestinal cancer. 2012. doi:10.1007/s12029-012-9418-x. PubMed
41.
Sato K, Yokouchi Y, Saida Y, Ito S, Kitagawa T, Maetani I. A small cell neuroendocrine carcinoma of the rectum diagnosed by colorectal endoscopic submucosal dissection. J Gastrointestin Liver Dis. 2012;21(2):128. PubMed.PubMed
42.
Izuishi K, Arai T, Ochiai A, Ono M, Sugito M, Tajiri H, et al. Long-term survival in advanced small cell carcinoma of the colorectum: report of a case. Surg Today. 2002;32(1):72–4. PubMed.PubMedCrossRef
43.
Molas G, Bougis-de-Brux MA, Potet F. [Small-cell anaplastic neuroendocrine carcinoma of the rectum]. Gastroenterol Clin Biol. 1987;11(12):904–7. PubMed.PubMed
44.
Shirouzu K, Morodomi T, Isomoto H, Ono S, Kakegawa T, Yasuaki F, et al. Long term survival case of small (oat) cell carcinoma of the rectum. Acta Pathol Jpn. 1987;37(1):111–6. PubMed.PubMed
Metadata
Title
Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data
Authors
Aram S Modrek
Howard C Hsu
Cynthia G Leichman
Kevin L Du
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2015
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-015-0411-y

Other articles of this Issue 1/2015

Radiation Oncology 1/2015 Go to the issue

Research

Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients

Research

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme

Research

Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR)

Research

Radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome in breast cancer patients is associated with age

Research

Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials

Research

Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia